These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Breaking down barriers to initiating insulin: Insulin prescription pad. Ali A; Cheng AY; Yu CH Can Fam Physician; 2015 May; 61(5):445-7. PubMed ID: 25971761 [No Abstract] [Full Text] [Related]
3. Adipose Tissue Responses to Breaking Sitting in Men and Women with Central Adiposity. Chen YC; Betts JA; Walhin JP; Thompson D Med Sci Sports Exerc; 2018 Oct; 50(10):2049-2057. PubMed ID: 29727403 [TBL] [Abstract][Full Text] [Related]
4. Breaking down barriers to insulin management in primary care. Williams R Prim Care Diabetes; 2010 Apr; 4 Suppl 1():vii-viii. PubMed ID: 20394892 [No Abstract] [Full Text] [Related]
5. Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. Jyung RW; Mustoe JA; Busby WH; Clemmons DR Surgery; 1994 Feb; 115(2):233-9. PubMed ID: 7508640 [TBL] [Abstract][Full Text] [Related]
6. Effects of breaking up prolonged sitting following low and high glycaemic index breakfast consumption on glucose and insulin concentrations. Bailey DP; Maylor BD; Orton CJ; Zakrzewski-Fruer JK Eur J Appl Physiol; 2017 Jul; 117(7):1299-1307. PubMed ID: 28500416 [TBL] [Abstract][Full Text] [Related]
7. Breaking sitting with light activities vs structured exercise: a randomised crossover study demonstrating benefits for glycaemic control and insulin sensitivity in type 2 diabetes. Duvivier BM; Schaper NC; Hesselink MK; van Kan L; Stienen N; Winkens B; Koster A; Savelberg HH Diabetologia; 2017 Mar; 60(3):490-498. PubMed ID: 27904925 [TBL] [Abstract][Full Text] [Related]
8. Abnormal insulin-receptor down regulation and dissociation of down regulation from insulin biological action in cultured human tumor cells. Mountjoy KG; Finlay GJ; Holdaway IM Cancer Res; 1987 Dec; 47(24 Pt 1):6500-4. PubMed ID: 3315189 [TBL] [Abstract][Full Text] [Related]
9. [BREAKING THE INSULIN IN RESISTANCE WITH ALPHA-METHYLDOPA]. MEYTHALER F; WEILER K Klin Wochenschr; 1964 Jun; 42():590-2. PubMed ID: 14236989 [No Abstract] [Full Text] [Related]
10. Insulin receptor down-regulation and impaired antilipolytic action of insulin in diabetic patients after pancreas/kidney transplantation. Boden G; Chen X; Ruiz J; Heifets M; Morris M; Badosa F J Clin Endocrinol Metab; 1994 Mar; 78(3):657-63. PubMed ID: 8126138 [TBL] [Abstract][Full Text] [Related]
11. [Insulin resistance. IV. Breaking through insulin intolerance with alpha-methyldopa]. Meythaler F; Kotlorz H Arztl Forsch; 1965 Aug; 19(8):433-46. PubMed ID: 5898035 [No Abstract] [Full Text] [Related]
12. Defective insulin receptor function in down-regulated HepG2 cells. Williams JF; Olefsky JM Endocrinology; 1990 Oct; 127(4):1706-17. PubMed ID: 2169397 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I and insulin down-regulate growth hormone (GH) receptors in rat osteoblasts: evidence for a peripheral feedback loop regulating GH action. Leung K; Rajkovic IA; Peters E; Markus I; Van Wyk JJ; Ho KK Endocrinology; 1996 Jul; 137(7):2694-702. PubMed ID: 8770888 [TBL] [Abstract][Full Text] [Related]
15. Chemical mediator of insulin action stimulates lipid synthesis and down regulates the insulin receptors in primary cultures of rat hepatocytes. Caro JF; Folli F; Cecchin F; Sinha MK Biochem Biophys Res Commun; 1983 Aug; 115(1):375-82. PubMed ID: 6311211 [TBL] [Abstract][Full Text] [Related]
16. Activin A impairs insulin action in cardiomyocytes via up-regulation of miR-143. Blumensatt M; Greulich S; Herzfeld de Wiza D; Mueller H; Maxhera B; Rabelink MJ; Hoeben RC; Akhyari P; Al-Hasani H; Ruige JB; Ouwens DM Cardiovasc Res; 2013 Nov; 100(2):201-10. PubMed ID: 23812417 [TBL] [Abstract][Full Text] [Related]
18. Effects of insulin on protein kinase-C (PKC) in HIRC-B cells: specific activation of PKC epsilon and its resistance to phorbol ester-induced down-regulation. Zhao L; Standaert ML; Cooper DR; Avignon A; Farese RV Endocrinology; 1994 Dec; 135(6):2504-10. PubMed ID: 7988438 [TBL] [Abstract][Full Text] [Related]
19. The oxazolidinedione CP-92,768-2 partially protects insulin receptor substrate-1 from dexamethasone down-regulation in 3T3-L1 adipocytes. Turnbow MA; Smith LK; Garner CW Endocrinology; 1995 Apr; 136(4):1450-8. PubMed ID: 7895655 [TBL] [Abstract][Full Text] [Related]